Atlas Venture Associates XI, 10% Owner: Xilio Therapeutics XLO Sell · Filed 24/02/09

Trade details

Type: Insider sale
Amount: $469.12
Shares · price: 733 sh · $0.64 a share
Held after: 2,019,563 sh
Stock: Xilio Therapeutics XLO
Person: Atlas Venture Associates XI10% Owner
Trade date: 24/02/08
Filed: 24/02/09
Days to filing: 1 days

Sold under 0.1% of holdings

Share of holding sold: under 0.1%

Xilio Therapeutics trades, last 26 weeks

What else happened in Xilio Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/09~24/03/09

Atlas Venture Associates XI's recent trades

Atlas Venture Associates XIShareholder
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$114.2K
5,000 sh
$114.2K
Filed 07/07
Traded 07/07
Atlas Venture Associates XIShareholder
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 plan
Dyne Therapeutics
DYN
$7,477
428 sh
$7,477
Filed 05/06
Traded 05/06
Atlas Venture Associates XIShareholder
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 plan
Dyne Therapeutics
DYN
$1,063
60 sh
$1,063
Filed 05/05
Traded 05/05
Atlas Venture Associates XIShareholder
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 plan
Dyne Therapeutics
DYN
$1,061
61 sh
$1,061
Filed 05/04
Traded 04/29
Atlas Venture Associates XIShareholder
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 plan
Dyne Therapeutics
DYN
$21.1K
1,171 sh
$21.1K
Filed 04/28
Traded 04/28